X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
Europe
0
Canada
Australia
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.reuters.com/markets/deals/pfizer-gets-ok-43-bln-seagen-deal-after-donating-cancer-drug-rights-2023-12-12/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761049
https://www.onclive.com/view/avelumab-increases-pfs-rates-in-dmmr-msi-metastatic-crc
https://www.onclive.com/view/post-hoc-analysis-confirms-safety-of-maintenance-avelumab-in-urothelial-carcinoma
https://www.prnewswire.com/news-releases/positive-results-from-interim-analysis-of-gen-001-plus-avelumab-bavencio-phase-ii-trial-301829278.html
https://endpts.com/merck-kgaa-takes-back-control-of-pd-l1-cancer-drug-as-pfizer-alliance-ends/
https://www.prnewswire.com/news-releases/promontory-therapeutics-presents-safety-and-efficacy-data-of-pt-112-in-combination-with-pd-l1-inhibition-in-treatment-of-advanced-non-small-cell-lung-cancer-at-esmo-i-o-2022-301697236.html
http://www.pharmafile.com/news/622374/nice-recommends-avelumab-urothelial-cancer-patients
https://www.pharmatimes.com/news/nice_overturns_previous_decision,_recommends_merck_and_pfizers_bavencio_1389963
https://www.globenewswire.com/news-release/2021/11/17/2335974/0/en/Imugene-Announces-Clinical-Trial-Supply-Agreement-with-Merck-KGaA-Darmstadt-Germany-and-Pfizer-to-Evaluate-HER-Vaxx-in-Combination-with-Avelumab-for-Treatment-of-Gastric-Cancer.html
https://www.firstwordpharma.com/node/1878800?tsid=4
https://www.clinicaltrialsarena.com/news/sheffield-university-breast-cancer-trial/
https://www.prnewswire.com/news-releases/nektar-announces-new-clinical-collaboration-with-merck-kgaa-darmstadt-germany-and-pfizer-inc-to-combine-nktr-255-a-novel-interleukin-15-agonist-with-avelumab-in-the-javelin-bladder-medley-study-301380966.html
https://breastcancernow.org/about-us/media/press-releases/aspirin-be-trialled-part-new-treatment-aggressive-form-breast-cancer#:~:text=An%20innovative%20new%20study%20is,people%20affected%20by%20breast%20cancer.
https://www.scottishmedicines.org.uk/about-us/latest-updates/august-2021-decisions-news-release/
https://ir.vaccinex.com/news-releases/news-release-details/vaccinex-announces-activation-clinical-sites-enroll-patients
https://www.nice.org.uk/news/article/avelumab-not-recommended-as-a-maintenance-treatment-of-urothelial-cancer-after-platinum-based-chemotherapy
http://www.pharmatimes.com/news/preliminary_nice_no_for_mercks_bavencio_1369309
https://www.newswire.ca/fr/news-releases/health-canada-approves-bavencio-r-for-the-maintenance-treatment-of-patients-with-advanced-bladder-cancer-817398194.html
https://www.prnewswire.com/news-releases/bavencio-avelumab-receives-positive-chmp-opinion-for-first-line-maintenance-treatment-of-locally-advanced-or-metastatic-urothelial-carcinoma-301191189.html
https://www.businesswire.com/news/home/20201203005865/en/Transgene-to-Present-Phase-1b2-Trial-Results-of-TG4001-in-Combination-with-avelumab-in-Advanced-HPV-Positive-Cancers-at-ESMO-IO-2020
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761049
https://www.biospace.com/article/releases/transgene-presents-e-poster-outlining-detailed-results-from-the-phase-1b-2-trial-of-tg4001-in-combination-with-avelumab-in-advanced-hpv-positive-cancers-at-sitc-2020/
https://www.prnewswire.com/news-releases/genome--company-announces-first-patient-dosed-in-phase-11b-study-of-gen-001-an-immuno-oncology-microbiome-therapeutic-in-combination-with-avelumab-301158564.html
http://www.pharmatimes.com/news/bavencio,_imbruvica_among_latest_smc_decisions_1353002
https://www.fiercepharma.com/pharma/esmo-bristol-myers-opdivo-racks-up-gi-cancer-data-for-two-potentially-practice-changing-fda
https://www.esmo.org/oncology-news/no-improvement-in-survival-with-avelumab-added-to-crt-in-locally-advanced-scchn#:~:text=No%20improvement%20in%20PFS%20was,in%20patients%20with%20LA%20SCCHN.&text=Fatal%20AEs%20occurred%20in%206,study%20drug%20due%20to%20AEs.
https://www.pfizer.com/news/press-release/press-release-detail/bavencio-pivotal-phase-iii-javelin-bladder-100-results
http://www.globenewswire.com/news-release/2020/09/17/2095586/0/en/Immutep-Reports-Improving-Results-from-INSIGHT-004-Trial.html
https://www.biospace.com/article/releases/phosplatin-therapeutics-announces-results-from-phase-1b-dose-escalation-study-of-pt-112-plus-avelumab-in-patients-with-solid-tumors/
https://www.biospace.com/article/releases/emd-serono-advances-oncology-portfolio-and-pipeline-with-new-and-long-term-data-in-multiple-cancers-at-esmo-2020/
https://www.nice.org.uk/guidance/ta645/resources/avelumab-with-axitinib-for-untreated-advanced-renal-cell-carcinoma-pdf-11452055183557#:~:text=Avelumab%20(Bavencio)%20with%20axitinib%20(,address%20uncertainties%20about%20the%20treatment.
http://www.pharmatimes.com/news/uk_bladder_cancer_patients_get_early_access_to_bavencio_1347799
http://www.pharmafile.com/news/558026/mhra-gives-ok-bavencio-first-line-maintenance-advanced-bladder-cancer-early-access-medic
http://www.pharmatimes.com/news/nice_green_light_for_immunotherapy_bavencio_1347615
https://www.globenewswire.com/news-release/2020/08/31/2086394/0/en/NKMax-America-Receives-FDA-Clearance-to-Amend-its-Current-Phase-I-Monotherapy-Trial-to-Include-an-Additional-New-Cohort-of-SNK01-Checkpoint-Inhibitor-in-Refractory-Solid-Tumors.html
http://www.pharmatimes.com/news/nice_backs_bavencio_combo_for_kidney_cancer_1346032
Market Place
Share 
